GREY:BNVIF - Post by User
Post by
RichyRich$on May 22, 2021 2:17am
169 Views
Post# 33253403
Had Anyone Noticed...
Had Anyone Noticed...That Binovi has $900K Cash. $100K Debt. And only $9M Operating Cashflow Loss last annual. I assume most of the OCF loss was a one-time initial setup cost with their recent push forward. Now that they're setup... the OCF loss will be less and reap the fruit of their hard work this year. Especially with the pandemic ending. I'm used to Biopharma stocks that are in huge debt and way way way worse OCF losses with R&D and marketing costs. Where Binovi's R&D period is finished and their marketing costs are minimal. The product pretty well sells itself with minimal sales needed... and in an essential industry of eye health. Am I the only one seeing this??? Seems like huge upside with little risk at this point and with such an attractively low share price? That's probably why so much volume of accumulation the past 2 weeks. Big players are strategically buying up at a set price around 6 cents... whole Retail investors are ignorantly jumping ship.